Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether people who have received intermittent
anti-VEGF therapy have an improvement in vision after being switched to monthly injections of
Lucentis.